Shionogi-Backed Apnimed Files for IPO to Fund Sleep Apnea Drug

Apnimed Inc. filed to conduct a US initial public offering. The company is developing an oral medication for obstructive sleep apnea treatment that is advancing toward commercialization. Shionogi backed the company.

Next story